Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
RAD Announcements
RAD202 Phase 1 HEAT Trial Advances to…
RAD
RADIOPHARM THERANOSTICS LIMITED
Market sensitive
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3
Date and time
8 April 2026 at 7:00 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
RAD announcement history
Recent RAD announcements
RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
Change in substantial holding
RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
Notice of Extraordinary General Meeting and Proxy Form
Share Purchase Plan - Now Open
Update - Proposed issue of securities - RAD